As of 14 Oct 2026, D3 Bio, Inc has raised $108M across 1 verified round on record; latest: $108 million Series B, announced 9 Dec 2025.
1 source
The source names investors but does not identify a lead. The Shanghai dateline does not establish headquarters.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series B [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $108M | 2025-12-09 | not stated | No recent discussion |
1 source [ VERIFIED · CORRECTED ] read against 1 source The source names investors but does not identify a lead. The Shanghai dateline does not establish headquarters. | ||||